Uterine Neoplasms
"Uterine Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UTERUS.
Descriptor ID |
D014594
|
MeSH Number(s) |
C04.588.945.418.948 C13.351.500.852.762 C13.351.937.418.875
|
Concept/Terms |
Uterine Neoplasms- Uterine Neoplasms
- Neoplasms, Uterus
- Neoplasm, Uterus
- Uterus Neoplasm
- Uterus Neoplasms
- Neoplasms, Uterine
- Neoplasm, Uterine
- Uterine Neoplasm
Cancer of Uterus- Cancer of Uterus
- Uterus Cancers
- Cancer of the Uterus
- Uterus Cancer
- Cancer, Uterus
- Cancers, Uterus
- Uterine Cancer
- Cancer, Uterine
- Cancers, Uterine
- Uterine Cancers
|
Below are MeSH descriptors whose meaning is more general than "Uterine Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uterine Neoplasms".
This graph shows the total number of publications written about "Uterine Neoplasms" by people in UAMS Profiles by year, and whether "Uterine Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 0 | 1 | 1 | 2023 | 1 | 0 | 1 | 2021 | 3 | 0 | 3 | 2020 | 3 | 0 | 3 | 2019 | 2 | 0 | 2 | 2018 | 2 | 0 | 2 | 2017 | 2 | 1 | 3 | 2016 | 3 | 0 | 3 | 2015 | 1 | 0 | 1 | 2014 | 2 | 0 | 2 | 2013 | 1 | 0 | 1 | 2012 | 1 | 1 | 2 | 2011 | 0 | 1 | 1 | 2010 | 2 | 0 | 2 | 2009 | 1 | 0 | 1 | 2007 | 3 | 0 | 3 | 2006 | 2 | 0 | 2 | 2005 | 6 | 0 | 6 | 2004 | 1 | 0 | 1 | 2003 | 1 | 1 | 2 | 2002 | 1 | 0 | 1 | 2000 | 2 | 0 | 2 | 1997 | 2 | 0 | 2 | 1996 | 1 | 0 | 1 | 1992 | 0 | 1 | 1 | 1990 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Uterine Neoplasms" by people in Profiles over the past ten years.
-
Gornet ME, Christianson MS, Stone RL. Robotic-assisted uterine transposition followed by anatomic pelvic repositioning for a patient with intramural fibroids and rectal cancer. Fertil Steril. 2024 Jul; 122(1):181-183.
-
Gama JM, Quick CM. Uterine alveolar soft part sarcoma - an unexpected case. Int J Gynecol Cancer. 2023 08 07; 33(8):1322-1323.
-
Katebi Kashi P, Hopkins MR, Stone RL. Placental site trophoblastic tumor versus exaggerated placental site: a diagnostic dilemma. Int J Gynecol Cancer. 2021 Oct; 31(10):1391-1392.
-
Schaefer SL, Strong AL, Bahroloomi S, Han J, Whisman MK, Wilkowski JM, Angeles CV. Large intraperitoneal lipoleiomyoma in a pre-menopausal woman: a case report. World J Surg Oncol. 2021 May 08; 19(1):144.
-
Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, Yao X, Deshpande A, Zaidi S, Guglielmi A, Gnutti B, Nagarkatti N, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Jeong K, Zhao S, Buza N, Hui P, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Ardighieri L, Bilguvar K, Quick CM, Silasi DA, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Imielinski M, Schwartz PE, Alexandrov LB, Lifton RP, Schlessinger J, Santin AD. Integrated mutational landscape analysis of uterine leiomyosarcomas. Proc Natl Acad Sci U S A. 2021 04 13; 118(15).
-
Erickson BK, Najjar O, Damast S, Blakaj A, Tymon-Rosario J, Shahi M, Santin A, Klein M, Dolan M, Cimino-Mathews A, Buza N, Ferriss JS, Stone RL, Khalifa M, Fader AN. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study. Gynecol Oncol. 2020 10; 159(1):17-22.
-
Hensley ML, Chavan SS, Solit DB, Murali R, Soslow R, Chiang S, Jungbluth AA, Bandlamudi C, Srinivasan P, Tap WD, Rosenbaum E, Taylor BS, Donoghue MTA, Hyman DM. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clin Cancer Res. 2020 07 15; 26(14):3881-3888.
-
Kolin DL, Quick CM, Dong F, Fletcher CDM, Stewart CJR, Soma A, Hornick JL, Nucci MR, Howitt BE. SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities. Am J Surg Pathol. 2020 02; 44(2):263-270.
-
Zheng G, Richmond A, Liu C, Berrebi A, Pallavajjala A, Haley L, Stone RL, McCarthy E, Vang R, Xing D. Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus. Int J Gynecol Pathol. 2019 Sep; 38(5):414-419.
-
Adams CL, Dimitrova I, Post MD, Gibson L, Spillman MA, Behbakht K, Bradford AP. Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma. Exp Mol Pathol. 2019 10; 110:104284.
-
Mirkovic J, McFarland M, Garcia E, Sholl LM, Lindeman N, MacConaill L, Dong F, Hirsch M, Nucci MR, Quick CM, Crum CP, McCluggage WG, Howitt BE. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract. Am J Surg Pathol. 2018 02; 42(2):227-233.
-
Pinto A, Kahn RM, Rosenberg AE, Slomovitz B, Quick CM, Whisman MK, Huang M. Uterine rhabdomyosarcoma in adults. Hum Pathol. 2018 04; 74:122-128.
-
Richmond AM, Blake EA, Torkko K, Smith EE, Spillman MA, Post MD. Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma. Int J Gynecol Cancer. 2017 11; 27(9):1895-1903.
-
Antosh DD, High R, Brown HW, Oliphant SS, Abed H, Philip N, Grimes CL. Feasibility of prophylactic salpingectomy during vaginal?hysterectomy. Am J Obstet Gynecol. 2017 11; 217(5):605.e1-605.e5.
-
Mizrahi DJ, Kaushik C, Adamo R. Hypovolemic Shock and Hemoperitoneum from Spontaneous Avulsion of a Large Pedunculated Uterine Leiomyoma. J Radiol Case Rep. 2017 Mar; 11(3):15-21.
-
McCourt CK, Deng W, Dizon DS, Lankes HA, Birrer MJ, Lomme MM, Powell MA, Kendrick JE, Saltzman JN, Warshal D, Tenney ME, Kushner DM, Aghajanian C. A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 Jan; 144(1):101-106.
-
Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, Black J, Cocco E, Choi J, Zammataro L, Predolini F, Bonazzoli E, Bi M, Buza N, Hui P, Wong S, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Odicino F, Pecorelli S, Donzelli C, Ardighieri L, Facchetti F, Falchetti M, Silasi DA, Ratner E, Azodi M, Schwartz PE, Mane S, Angioli R, Terranova C, Quick CM, Edraki B, Bilg?var K, Lee M, Choi M, Stiegler AL, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition. Proc Natl Acad Sci U S A. 2016 10 25; 113(43):12238-12243.
-
McFarland M, Quick CM, McCluggage WG. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology. 2016 Jun; 68(7):1013-20.
-
Parra-Herran C, Quick CM, Howitt BE, Dal Cin P, Quade BJ, Nucci MR. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course. Am J Surg Pathol. 2015 Feb; 39(2):157-68.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|